Department of Thrombosis and Hemostasis, Leiden University Medical Centre LUMC, C-4-70, Postbus 9600, 2300 RC Leiden, The Netherlands.
Thromb Haemost. 2013 Jan;109(1):47-52. doi: 10.1160/TH12-07-0466. Epub 2012 Nov 8.
The aim of this study is to compare the performance of two clinical decision rules to select patients with acute pulmonary embolism (PE) for outpatient treatment: the Hestia criteria and the simplified Pulmonary Embolism Severity Index (sPESI). From 2008 to 2010, 468 patients with PE were triaged with the Hestia criteria for outpatient treatment: 247 PE patients were treated at home and 221 were treated as inpatients. The outcome of interest was all-cause 30-day mortality. In a post-hoc fashion, the sPESI items were scored and patients were classified according to the sPESI in low and high risk groups. Of the 247 patients treated at home, 189 (77%) patients were classified as low risk according to the sPESI and 58 patients (23%) as high risk. In total, 11 patients died during the first month; two patients treated at home and nine patients treated in-hospital. None of the patients treated at home died of fatal PE. Both the Hestia criteria and sPESI selected >50% of patients as low risk, with good sensitivity and negative predictive values for 30-day mortality: 82% and 99% for the Hestia criteria and 91% and 100% for the sPESI, respectively. The Hestia criteria and the sPESI classified different patients eligible for outpatient treatment, with similar low risks for 30-day mortality. This study suggests that the Hestia criteria may identify a proportion of high risk sPESI patiennts who can be safely treated at home, this however requires further validation.
本研究旨在比较两种临床决策规则(Hestia 标准和简化的肺栓塞严重指数[sPESI])用于选择急性肺栓塞(PE)患者进行门诊治疗的表现。2008 年至 2010 年,468 例 PE 患者采用 Hestia 标准进行门诊治疗分诊:247 例 PE 患者在家中治疗,221 例患者住院治疗。主要结局为全因 30 天死亡率。事后,对 sPESI 项目进行评分,并根据 sPESI 将患者分为低危和高危组。在家中治疗的 247 例患者中,189 例(77%)患者根据 sPESI 被分类为低危,58 例(23%)患者为高危。总的来说,有 11 例患者在第一个月死亡;2 例在家中治疗的患者和 9 例住院治疗的患者。在家中治疗的患者均未死于致命性 PE。Hestia 标准和 sPESI 均选择了>50%的患者为低危,对 30 天死亡率具有良好的敏感性和阴性预测值:Hestia 标准为 82%和 99%,sPESI 为 91%和 100%。Hestia 标准和 sPESI 对适合门诊治疗的患者进行了分类,两者的 30 天死亡率的低危风险相似。本研究表明,Hestia 标准可能可以识别一部分高危 sPESI 患者,他们可以安全地在家中治疗,但这需要进一步验证。